Stay updated on Safe Doses CX-188 in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Safe Doses CX-188 in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safe Doses CX-188 in Solid Tumors Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.2%
    Check dated 2024-06-13T22:22:06.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the information related to the first-in-human study of CX-188 for adult subjects with metastatic or advanced unresectable solid tumors. This change may be significant for individuals monitoring medical and healthcare-related publications and documentation.
    Difference
    0.2%
    Check dated 2024-06-06T14:36:29.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to provide detailed eligibility criteria for study participants, including specific health conditions and prior treatments required for inclusion. Previously, this section only indicated that no information was provided.
    Difference
    21%
    Check dated 2024-05-22T21:36:49.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    2%
    Check dated 2024-04-30T22:32:27.000Z thumbnail image

Stay in the know with updates to Safe Doses CX-188 in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safe Doses CX-188 in Solid Tumors Clinical Trial page.